false

Anna Rodecki

Anna Rodecki is a results driven leader with 24 years of experience in clinical research across the pharmaceutical, device, and biotech industries. She has played a pivotal role in shaping clinical development plans on both Sponsor and CRO, successfully supporting First- In-Human (FIH) – Phase IV trials successfully across various therapeutics areas. Anan thrives on building strong, collaborative teams fostering innovation. Her expertise spans strategic planning, risk management, inspection readiness and cross-functional leadership – always with a focus on improving patient outcomes and advancing the future of medicine.

• Read: Case Study: Concurrent Phase 1 Solid Tumor Drug Development Successes

  Clinical Trials

  Case Study: Concurrent Phase 1 Solid Tumor Drug Development Successes

  Feb 24, ‘25 | 4 min read

  • 

  • Anna R.

    Kurt P.

  Discover
• Read: Case Study Phase 3 NSCLC: Site Relationships Streamline Feasibility

  Clinical Trials

  Case Study Phase 3 NSCLC: Site Relationships Streamline Feasibility

  Feb 10, ‘25 | 5 min read

  • 

    Anna Rodecki

  Discover

Loading...

You've reach the end Back to top